Selective publication of antidepressant trials and its influence on apparent efficacy: Updated comparisons and meta-analyses of newer versus older trials

Turner et al. (Wed,) studied this question.

www.synapsesocial.com/papers/69dcc7fda5c75be4cfe5437c — DOI: https://doi.org/10.1371/journal.pmed.1003886

Also consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. Assay Sensitivity, Failed Clinical Trials, and the Conduct of Science· 2002 · 42 citations
2. GlaxoSmithKline to publish clinical trials after US lawsuit· 2004 · 31 citations
3. Efficacy and Safety of Levomilnacipran Sustained Release in Moderate to Severe Major Depressive Disorder· 2013 · 78 citations
4. Hiding negative trials by pooling them: a secondary analysis of pooled-trials publication bias in FDA-registered antidepressant trials· 2018 · 29 citations
5. Publication Bias, with a Focus on Psychiatry: Causes and Solutions· 2013 · 64 citations